advanced search

CONNECTIVITY

HARNESSING HUMAN FACTORS IN CONNECTED DEVICE DEVELOPMENT
CONNECTIVITY
Finola Austin
Owen Mumford
HARNESSING HUMAN FACTORS IN CONNECTED DEVICE DEVELOPMENT
Finola Austin looks at the role human factors testing plays in the development of connected drug delivery devices.
BEYOND THE EYEDROPPER BOTTLE – THREE WAYS TO IMPROVE ADHERENCE
EXPERT VIEW
Dr Nathan Wilkinson
BEYOND THE EYEDROPPER BOTTLE – THREE WAYS TO IMPROVE ADHERENCE
Nathan Wilkinson, Catherine Wyman and Matt Parker discuss the future outlook of ophthalmic drug delivery beyond the traditional eyedropper bottle, including new delivery technologies, sustained-release therapeutics and digital healthcare applications.
Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting
INTERVIEW
Dr Ben Cox
Team Consulting
Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting
With Pharmapack returning to its traditional February timing in 2023, Team Consulting will be chairing a Day 1 expert panel discussion on patient-centric digital health solutions. Interviewed here, Ben Cox provides insight into trends the panel will discuss, lays out the current status of the industry with respect to digital health and considers what to look forward to at Pharmapack this year.
DESIGNING EFFECTIVE AND ENGAGING DIGITAL SOLUTIONS TO DRIVE ADHERENCE
CONNECTIVITY
Florian Krummenacher
Ypsomed
DESIGNING EFFECTIVE AND ENGAGING DIGITAL SOLUTIONS TO DRIVE ADHERENCE
Florian Krummenacher and Philippe Müller discuss the effectiveness of combining connected injection devices with digital solutions to drive therapy outcomes.
CONNECTED DRUG DELIVERY DEVICES: BENEFITS AND CYBERSECURITY
EXPERT VIEW
João Budzinski
CONNECTED DRUG DELIVERY DEVICES: BENEFITS AND CYBERSECURITY
João Budzinski discusses the benefits of connected drug delivery devices and the importance of cybersecurity when developing them, including the threats, key considerations and potential solutions.
PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT
CONNECTIVITY
Mark Tunkel
Nemera
PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT
Mark Tunkel and Cécile Gross consider the development of connected drug delivery devices and identify how understanding the patient journey from diagnosis to treatment can be used as an early-stage decision-making tool.
BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS
CONNECTIVITY
Benjamin D’hont
Aptar Pharma
BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS
Benjamin D’hont and Joe Reynolds discuss how the key to maturing the digital health market and increasing user retention of digital health apps is integrating agile app development from the beginning of a therapeutic’s development cycle.
Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden
INTERVIEW
Dr Oliver Eden
Jabil Healthcare
Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden
Oliver Eden of Jabil Healthcare looks at the factors influencing the return on investment metrics in clinical development and introduces Jabil’s autoinjector platform Qfinity™ and its connected version, Qfinity+™.
ADVANCEMENTS IN MONITORING ADHERENCE – A SMART MESH NEBULISER
CONNECTIVITY
Edgar Hernan Cuevas Brun
HCmed Innovations
ADVANCEMENTS IN MONITORING ADHERENCE – A SMART MESH NEBULISER
Edgar Hernan Cuevas Brun and Yuan-Ming Hsu consider patient adherence and the role HCmed Innovations’ AdheResp mesh nebuliser plays in monitoring adherence.
DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS
CONNECTIVITY
Dr Haykel Ben Jamaa
Sensirion
DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS
Haykel Ben Jamaa explores why modern society needs digital health and how it is organised and implemented, with a focus on sensing technologies empowering digital health technologies.
AREAS TO WATCH IN CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT
CONNECTIVITY
Michael Earl
Owen Mumford
AREAS TO WATCH IN CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT
Michael Earl identifies areas of development in the field of connected drug delivery devices, providing an insight into what can be expected in the coming years. He draws on Owen Mumford’s own research, as well as discussions with industry experts and counterparts.
COULD VIVERA BE THE NEXT MEDTECH UNICORN START-UP?
CONNECTIVITY
Amanda Whitcroft
Vivera Pharmaceuticals
COULD VIVERA BE THE NEXT MEDTECH UNICORN START-UP?
Few technology companies reach unicorn status. US medtech company Vivera is hoping to be the next one, with its innovative approach to prescription drug delivery that aims to increase patient adherence and stop prescription drug abuse.
CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA
SUSTAINABILITY
Dr Iain Simpson
Phillips Medisize
CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA
Iain Simpson and Vinith Bhandari consider the sustainability impact of device connectivity specific to asthma inhalers through the reduction of greenhouse gas emissions.
Interview with Biocorp’s Arnaud Guillet
INTERVIEW
Arnaud Guillet
Biocorp
Interview with Biocorp’s Arnaud Guillet
In this exclusive interview, Arnaud Guillet of Biocorp talks with ONdrugDelivery about connectivity in the injectables space, sharing some of the insights Biocorp has gained from its decade of experience in developing connected drug delivery devices.
Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector
INJECTION
Barbara Taylor
Portal Instruments
Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector
Portal Instruments showcases its Prime needle-free drug delivery platform, and makes the case that there is a significant opportunity to transform the patient experience with a reusable and connected needle-free injector.
Technology Showcase: I-Platform from CCBio – How to Upgrade a Device in One Platform
INJECTION
Jimmy Fan
CC Bio
Technology Showcase: I-Platform from CCBio – How to Upgrade a Device in One Platform
CCBio showcases its I-Platform injectable drug delivery solution comprising: delivery units, including the electronic, connected Tesla device; containers and adapters; and safety needles.
OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS
WEARABLES
Cecile Gross
Nemera
OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS
Cécile Gross discusses the unmet drug delivery needs in chronic diseases, and details how Nemera’s answer – the Symbioze® on-body injector – fulfils these needs.
TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY
CONNECTIVITY
Mindy Katz
TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY
Mindy Katz discusses the benefits of integrating homecare technologies that are patient centric and connected.
MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE
CONNECTIVITY
Chelsea Williams
SHL Medical
MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE
Chelsea Williams, Nagisa Kobashi and Nils Weber discuss the digital transformation of injectables, where drug formulation and device are enmeshed within a connected ecosystem powered by patient data.
A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!
CONNECTIVITY
Aurelie Pager
BD (Becton Dickinson & Company)
A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!
 Aurélie Pager and Mircea Despa follow up on an article published in the December 2021 issue of ONdrugDelivery. BD has now completed a human factors study assessing the usability, acceptance and ease of use of its connected injection prototype for clinical trials.
PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS
CONNECTIVITY
Dr Andreas Schneider
Ypsomed
PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS
Andreas Schneider and Philippe Müller discuss the potential benefits and challenges of implementing connected device-digital solutions within the healthcare sector to improve the treatment of chronic conditions.
FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS
EXPERT VIEW
Dr Bernard Vrijens
FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS
Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.
CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS
CONNECTIVITY
Gemma Wood
Bespak
CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS
Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.
A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM
CONNECTIVITY
Marcel Botha
Aero Pump
A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM
Marcel Botha, Andreas Bilstein, Houssam Elghobary and Rouven Kraus discuss the benefits of the Validose digital health platform for the safe delivery of high-value and/or high-risk products.
Top